Amneal Pharmaceuticals, Inc. Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Amneal Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Amneal Pharmaceuticals, Inc. for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2020 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Buy | P | 2.71 | 204,210 | 553,409 | 353,649 | 149.4 K to 353.6 K (+136.65 %) |
| Mar 19 2020 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Buy | P | 2.79 | 149,439 | 416,935 | 149,439 | 0 to 149.4 K |
| Mar 16 2020 | AMRX | Amneal Pharmaceuti ... | Konidaris Tasos | SVP and CFO | Option Exercise | A | 0.00 | 701,754 | 0 | 701,754 | |
| Mar 16 2020 | AMRX | Amneal Pharmaceuti ... | Konidaris Tasos | SVP and CFO | Option Exercise | A | 0.00 | 350,877 | 0 | 350,877 | |
| Mar 11 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO and Director | Buy | P | 3.09 | 100,000 | 309,000 | 356,107 | 256.1 K to 356.1 K (+39.05 %) |
| Mar 11 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President, Co-CEO & ... | Buy | P | 3.09 | 100,000 | 309,000 | 356,107 | 256.1 K to 356.1 K (+39.05 %) |
| Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President, Co-CEO & ... | Buy | P | 3.97 | 58,938 | 233,984 | 256,107 | 197.2 K to 256.1 K (+29.89 %) |
| Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President, Co-CEO & ... | Buy | P | 3.88 | 156,421 | 606,913 | 197,169 | 40.7 K to 197.2 K (+383.87 %) |
| Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President, Co-CEO & ... | Buy | P | 3.87 | 34,641 | 134,061 | 40,748 | 6.1 K to 40.7 K (+567.23 %) |
| Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Buy | P | 3.94 | 117,889 | 464,483 | 156,107 | 38.2 K to 156.1 K (+308.46 %) |
| Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Buy | P | 3.88 | 32,111 | 124,591 | 38,218 | 6.1 K to 38.2 K (+525.81 %) |
| Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO and Director | Buy | P | 3.97 | 58,765 | 233,297 | 256,107 | 197.3 K to 256.1 K (+29.78 %) |
| Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO and Director | Buy | P | 3.88 | 156,539 | 607,371 | 197,342 | 40.8 K to 197.3 K (+383.65 %) |
| Mar 10 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO and Director | Buy | P | 3.87 | 34,696 | 134,274 | 40,803 | 6.1 K to 40.8 K (+568.13 %) |
| Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | M | 0.00 | 11,728 | 0 | 35,186 | |
| Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Payment of Exercise | F | 3.85 | 4,228 | 16,278 | 176,611 | 180.8 K to 176.6 K (-2.34 %) |
| Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Buy | M | 0.00 | 11,728 | 0 | 180,839 | 169.1 K to 180.8 K (+6.94 %) |
| Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | M | 0.00 | 12,345 | 0 | 37,038 | |
| Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Payment of Exercise | F | 3.85 | 6,683 | 25,730 | 101,630 | 108.3 K to 101.6 K (-6.17 %) |
| Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Buy | M | 0.00 | 12,345 | 0 | 108,313 | 96 K to 108.3 K (+12.86 %) |
| Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Option Exercise | M | 0.00 | 11,111 | 0 | 33,333 | |
| Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Payment of Exercise | F | 3.85 | 6,162 | 23,724 | 251,794 | 258 K to 251.8 K (-2.39 %) |
| Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Buy | M | 0.00 | 11,111 | 0 | 257,956 | 246.8 K to 258 K (+4.50 %) |
| Mar 03 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Buy | P | 3.62 | 40,000 | 144,800 | 246,845 | 206.8 K to 246.8 K (+19.34 %) |
| Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Option Exercise | A | 0.00 | 237,468 | 0 | 237,468 | |
| Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Option Exercise | A | 0.00 | 118,734 | 0 | 118,734 | |
| Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | A | 0.00 | 284,960 | 0 | 284,960 | |
| Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | A | 0.00 | 142,480 | 0 | 142,480 | |
| Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO and Director | Option Exercise | A | 0.00 | 1,266,490 | 0 | 1,266,490 | |
| Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President, Co-CEO & ... | Option Exercise | A | 0.00 | 1,266,490 | 0 | 1,266,490 | |
| Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Manzano Stephen | SVP, General Counse ... | Option Exercise | A | 0.00 | 131,926 | 0 | 131,926 | |
| Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Manzano Stephen | SVP, General Counse ... | Option Exercise | A | 0.00 | 65,963 | 0 | 65,963 | |
| Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Branning Todd P. | SVP and CFO | Option Exercise | A | 0.00 | 166,226 | 0 | 166,226 | |
| Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | Branning Todd P. | SVP and CFO | Option Exercise | A | 0.00 | 83,113 | 0 | 83,113 | |
| Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | A | 0.00 | 253,298 | 0 | 253,298 | |
| Mar 02 2020 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | A | 0.00 | 126,649 | 0 | 126,649 |